Trademark Overview
On Monday, June 1, 2026, a trademark application was filed for BIOSIGN with the United States Patent and Trademark Office. The USPTO has given the BIOSIGN trademark a serial number of 99857583. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, June 1, 2026. This trademark is owned by Princeton Biomeditech Corporation. The BIOSIGN trademark is filed in the Pharmaceutical Products category with the following description:
Pregnancy testing preparations; Pregnancy test kits for home and professional use; Diagnostic reagents for use in veterinary testing for feline leukemia virus, feline immunodeficiency virus, canine heartworm antigen, canine parvovirus, sulfamethazine, foot-and-mouth disease virus, porcine reproductive and respiratory syndrome virus, classical swine fever virus, West Nile virus; Diagnostic reagents for medical purposes for use in the medical testing for rubella, chlamydia, Lyme, streptococcus, infectious mononucleosis, Helicobacter pylori, influenza, SARS-CoV-2, respiratory syncytial virus, salmonella, listeria, Escherischia coli, malaria, Trypanosoma cruzi, Mycoplasma tuberculosis, human immunodeficiency virus, hepatitis, bladder tumor antigen, hemoglobin, thyroid stimulating hormone, follicle stimulating hormone, prostate specific antigen, alpha fetoprotein, carcinoembryonic antigen, pepsinogen, Troponin I, creatine kinase, myoglobin, myosin light chain, C-reactive protein
